申请人:PLETTENBURG Oliver
公开号:US20100056553A1
公开(公告)日:2010-03-04
The invention relates to 6-substituted isoquinoline and isoquinolinone derivatives of the formula (I)
useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
本发明涉及公式(I)的6-取代的异喹啉和异喹啉酮衍生物,可用于治疗和/或预防与Rho-激酶和/或Rho-激酶介导的肌球蛋白轻链磷酸酶的磷酸化相关的疾病,以及含有这些化合物的组合物。